Same Indication

Levodopa vs Tofacitinib

Levodopa vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Levodopa and Tofacitinib.

Mechanism of Action

Levodopa: Metabolic precursor of dopamine that crosses the BBB.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Levodopa β€” 1.5 hours; Tofacitinib β€” 3.2 hours.

Chemical Properties

Molecular Formula: Levodopa β€” C9H11NO4; Tofacitinib β€” C16H20N6O.

Molecular Weight: Levodopa β€” 197.1880 g/mol; Tofacitinib β€” 312.3700 g/mol.

Type: Levodopa β€” Small molecule; Tofacitinib β€” Small molecule.